- Yuexin is director at Life Sciences team. He is involved in the investments of Amolyt (acquired by AZ), ReViral (acquired by Pfizer), LogicBio (acquired by Alexion), Mineralys (MLYS), Evommune (EVMN), Tubulis, TargED, Alveus, Adcytherix, Artios, and JenaValve.
- Before joining Andera, Yuexin was at 3H Health Investment Hong Kong and Shanghai offices where he made the investments of InnoCare (HK.9969, SH.688428), KeyMed (HK.2162), CanSino (HK.6185), RareStone, EdiGen, Imperative Care, and HeMo Bioengineering. Prior to VC life, Yuexin has worked on Remicade and Keytruda’s life cycle management at Merck.
- Yuexin has a pharma degree from SJTU and a business degree from HEC Paris.
- He speaks Chinese, English and French.
Investments of Yuexin
Alveus Therapeutics
Clinical-stage biotechnology company developing next-generation therapies for obesity and metabolic diseases
Adcytherix
Biotech company focused on the development of antibody drug conjugates for high unmet need diseases such as cancer
Mineralys Therapeutics
Clinical-stage biopharmaceutical company committed to developing a best-in-class, novel therapy for the treatment of hypertension
Tubulis
Antibody drug conjugates for the treatment of cancer
Targed
Biotechnology company focused on developing improved treatments for thrombotic diseases
Amolyt Pharma
Developing therapeutic peptides for rare endocrine and related diseases
Evommune
Biopharmaceutical company developing innovative therapies in the field of chronic inflammation
Artios Pharma
Small molecules for the treatment of cancer
The team andera Life Sciences
Raphaël Wisniewski
Partner
Olivier Litzka
Partner
Sofia Ioannidou
Partner
Jan Van den Bossche
Partner
Aneta Sottil
Partner
Mathieu Piéronne
Director
Yuexin Yu
Director
Yanis Feraoun
Investment Manager
Natali Romero Barrios
Senior Investment Manager
Elyes Chouaieb
Investment Director
Loan Hoang-Sayag
Venture Partner
Florian Gerard-Mercier
Investment Director
Thierry Hercend
Venture Partner
Armelle Okoye
Middle Office
Hans J. Moebius
Venture Advisor
Raymond W. Cohen
Venture Advisor
Vanessa Bonvalot
Executive Assistant